BrainCells, INC (BCI) is a leading-edge neurogenesis-based drug discovery and development company targeting novel therapies for depression, mood disorders and other CNS diseases. Neurogenesis is emerging as a fundamental mechanism underlying CNS physiology and provides an opportunity for a paradigm-shifting approach to the treatment of CNS disease. BCI believes that, by targeting neurogenesis mechanisms with small molecule therapeutics, we will be able to develop and take to market first-in-class therapies for depression, mood disorders and other major CNS diseases.
Furthermore, BCI believes that the neurogenesis platform will provide a predictive pre-clinical model which will enhance the productivity of CNS drug research and reduce late-stage clinical attrition in the product pipeline.
| Contact Details: |
| 10835 Road To The Cure, Suite 150 |
| San Diego |
| California |
| 92121 |
| United States of America |
| Tel: | 1 858 812 7700 |
| Fax: | 1 858 812 7630 |
| Email: | ehodgkin@braincellsinc.com |
| WWW: | www.braincellsinc.com/

|
|
Loading...
|
Recent Publications by BrainCells: |  |
The status of nutraceuticals for the treatment of depression.
Currently, there are no specific markers available for the early detection... | 27th October, 2009
| Dr. Targum is an executive-in-residence at Oxford BioScience Partners and
| Psychiatry (Edgmont). 2009 Sep;6(9):46-8.
|
Cognition and schizophrenia: is there a role for cognitive assessments in diagnosis and treatment?
Currently, there are no specific markers available for the early detection... | 3rd September, 2009
| Dr. Targum is an executive-in-residence at Oxford BioScience Partners and
| Psychiatry (Edgmont). 2008 Dec;5(12):55-9.
|
Clinical applications of neuroimaging for treating depressive disorders.
Currently, there are no specific markers available for the early detection... | 3rd September, 2009
| Dr. Targum is an executive-in-residence at Oxford BioScience Partners and
| Psychiatry (Edgmont). 2009 Jun;6(6):49-51.
|
Seasonal affective disorder.
Currently, there are no specific markers available for the early detection... | 1st May, 2008
| Dr. Targum is an executive-in-residence at Oxford BioScience Partners, on
| Psychiatry (Edgmont). 2008 May;5(5):31-3.
|
Biomarkers for the identification and treatment of dementia.
Currently, there are no specific markers available for the early detection... | 1st February, 2008
| Dr. Targum is an executive-in-residence at Oxford BioScience Partners and
| Psychiatry (Edgmont). 2008 Feb;5(2):51-6.
|
→View more BrainCells research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 275 times since April 2007, the link to the organisation's website has been followed 47 times
Search for more companies in San Diego
Search for more companies in California
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
BrainCells